Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.37 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.37 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50496 | 0.88 | DPP4 (0.49) | ALDH1A1DPP4CYP2A6CYP2A13CYP2E1 | |
| SCHEMBL16888821 | 0.83 | ALDH1A1 (0.39) | ALDH1A1DPP4CYP2A6CYP2A13CYP2E1 | |
| SCHEMBL15040939 | 0.79 | ALDH1A1 (0.44) | ALDH1A1DPP4CYP2A6CYP2A13CYP2E1 | |
| SCHEMBL50725 | 0.77 | ALDH1A1 (0.46) | ALDH1A1DPP4CYP2A6CYP2E1CYP3A4 | |
| SCHEMBL1959113 | 0.77 | ALDH1A1 (0.39) | ALDH1A1DPP4CYP2A6CYP2E1CYP3A4 | |
| SCHEMBL1957123 | 0.75 | ALDH1A1 (0.38) | ALDH1A1DPP4KDM4EPOLB | |
| 2,5-Thiophenenedicarboxaldehyde SCHEMBL178830 | 0.74 | — | — | |
| SCHEMBL28791779 | 0.74 | ALDH1A1 (0.35) | ALDH1A1DPP4CYP2A6CYP2E1CYP3A4 | |
| SCHEMBL13237821 | 0.74 | ALDH1A1 (0.44) | ALDH1A1DPP4APPKDM4EMAPT | |
| SCHEMBL17009479 | 0.74 | ADH1A (0.40) | ALDH1A1KDM4EGAAMAPTCHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118124-A | Nitrogen-rich DOPO-based flame retardant, synthesis and application thereof | 常州大学 | 2025-06-10 | — | — | CN | claimed |
| CN-119912625-A | Preparation process of methacrylate film-forming resin with high sensitivity and high sensitivity | 和也健康科技有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119192132-A | Preparation method and application of biostable compound | 中山大学 | 2024-12-27 | — | — | CN | claimed |
| CN-104945307-A | Benzoindolyl salt material and nonlinear optical crystal thereof, and preparation method and application thereof | UNIV BEIJING SCIENCE & TECH | 2015-09-30 | — | — | CN | claimed |
| CN-102351851-A | 4-(5-dimethylaminothiophenevinyl)methylpyridine sulfonate, second-order nonlinear optical crystal of 4-(5-dimethylaminothiophenevinyl)methylpyridine sulfonate, and their preparation methods | UNIV BEIJING SCIENCE & TECH | 2012-02-15 | — | — | CN | claimed |
| JP-10030061-A | — | — | None | — | — | JP | disclosed |
| US-20260049073-A1 | SPECTACLE LENS COMPRISING AN ORGANIC DYE | OAKLEY, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| CN-118852156-B | Neutral dye probe based on G-quadruplex targeting, synthesis method and application | 衡阳师范学院 | 2025-10-17 | — | — | CN | disclosed |
| CN-120118124-A | Nitrogen-rich DOPO-based flame retardant, synthesis and application thereof | 常州大学 | 2025-06-10 | — | — | CN | disclosed |
| CN-119912625-A | Preparation process of methacrylate film-forming resin with high sensitivity and high sensitivity | 和也健康科技有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119192132-A | Preparation method and application of biostable compound | 中山大学 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024226717-A1 | SPECTACLE LENS COMPRISING AN ORGANIC DYE | OAKLEY, INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| WO-2004009602-A1 | PYRAZOLOPYRIMIDINES AS KINASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-01-29 | — | — | WO | disclosed |
| JP-H1030061-A | METALLIC COMPLEX COLORING MATTER, HEAT-SENSITIVE TRANSFER IMAGE-FORMING MATERIAL, FORMATION OF IMAGE AND FORMATION OF HEAT-SENSITIVE TRANSFER IMAGE | KONICA CORP | 1998-02-03 | — | — | JP | disclosed |
| US-5292896-A | Electrography, durability | RICOH COMPANY, LTD. (JP) | 1994-03-08 | — | — | US | disclosed |
| US-5072043-A | STYRENE DERIVATIVES AND ELECTROPHOTOGRAPHIC PHOTOCONDUCTOR COMPRISING ONE OF THE STYRENE DERIVATIVES | RICOH COMPANY, LTD. (JP) | 1991-12-10 | — | — | US | disclosed |
| EP-0200947-B1 | 1,3-DISUBSTITUTED IMIDAZOLIUM SALTS | F. HOFFMANN-LA ROCHE AG (CH) | 1990-09-12 | — | — | EP | disclosed |
| US-4831151-A | NEMATOCIDES | HOFFMANN-LA ROCHE INC. (US) | 1989-05-16 | — | — | US | disclosed |
| CN-86102906-A | Preparation 1, the method for the two substituted imidazole salt of 3- | — | 1987-02-11 | — | — | CN | disclosed |
| US-4603097-A | Styrene derivatives and electrophotographic photoconductor comprising one of the styrene derivatives | RICOH COMPANY, LIMITED (JP) | 1986-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049073-A1 | SPECTACLE LENS COMPRISING AN ORGANIC DYE | STRA6, TCOF1, CLIC1 | ALDH1A1 873/4885DPP4 3270/4885CYP2A6 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.